3007

SHZ:300760

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

  • Stock

CNY

Last Close

228.20

30/08 07:04

Market Cap

341.20B

Beta: 0.05

Volume Today

11.77M

Avg: 2.91M

PE Ratio

30.35

PFCF: 43.39

Dividend Yield

3.09%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
960.73M
-
1.02B
5.79%
1.30B
27.84%
1.63B
25.70%
1.98B
21.34%
2.90B
46.47%
3.55B
22.41%
3.80B
6.81%
4.00B
5.45%
average payables
637.45M
-
663.57M
4.10%
839.93M
26.58%
969.58M
15.44%
1.09B
12.64%
1.37B
25.60%
1.89B
37.80%
2.29B
20.92%
2.49B
8.95%
average receivables
1.54B
-
1.32B
14.43%
1.45B
9.92%
1.78B
23.19%
1.98B
11.14%
2.06B
3.91%
2.10B
2.10%
2.63B
25.21%
3.43B
30.35%
book value per share
10.08
-
6.86
31.90%
4.55
33.76%
6.06
33.27%
13.61
124.65%
15.29
12.35%
19.15
25.20%
22.19
15.87%
26.43
19.13%
27.34
3.45%
capex per share
-0.64
-
-0.64
0.80%
-0.42
35.13%
-0.43
2.70%
-0.61
42.58%
-0.64
4.91%
-0.97
52.24%
-1.15
18.67%
-1.58
37.13%
-2.22
40.36%
capex to depreciation
-1.89
-
-1.46
22.82%
-1.57
7.68%
-2.05
30.53%
-1.97
3.73%
-2.51
27.15%
-2.00
20.07%
-2.16
8.09%
-2.59
19.55%
capex to operating cash flow
-0.34
-
-0.29
12.94%
-0.14
53.75%
-0.14
3.94%
-0.17
18.88%
-0.16
2.13%
-0.13
18.96%
-0.16
16.89%
-0.16
1.23%
-0.24
51.91%
capex to revenue
-0.08
-
-0.07
1.06%
-0.05
38.38%
-0.04
8.77%
-0.05
18.07%
-0.05
4.85%
-0.06
19.88%
-0.06
1.33%
-0.06
13.66%
-0.08
23.31%
cash per share
1.93
-
2.18
12.76%
4.49
106.53%
4.85
7.88%
10.37
113.86%
11.65
12.41%
12.97
11.32%
12.51
3.56%
19.16
53.18%
15.53
18.97%
days of inventory on hand
117.17
-
120.73
3.04%
117.79
2.44%
155.30
31.84%
134.88
13.14%
143.63
6.48%
175.45
22.16%
147.17
16.12%
134.96
8.29%
115.56
14.38%
days payables outstanding
80.10
-
77.88
2.76%
77.80
0.11%
98.96
27.19%
74.66
24.55%
78.89
5.67%
74.31
5.82%
94.16
26.71%
76.81
18.43%
78.14
1.74%
days sales outstanding
77.21
-
64.65
16.27%
49.04
24.14%
54.89
11.93%
50.01
8.88%
45.80
8.42%
35.41
22.70%
31.26
11.71%
37.25
19.18%
39.72
6.62%
debt to assets
0.11
-
0.15
42.25%
0.27
78.81%
0.21
23.97%
0.07
66.74%
0.06
19.56%
0.04
24.92%
0.01
85.07%
0.01
18.73%
0.00
19.92%
debt to equity
0.17
-
0.30
76.44%
0.78
164.60%
0.45
42.23%
0.10
78.24%
0.08
22.27%
0.06
22.08%
0.01
85.25%
0.01
15.98%
0.01
20.61%
dividend yield
0.00
-
0.05
7,407.86%
0.09
77.73%
0.01
91.47%
0.01
0.91%
0.01
31.59%
0.00
35.95%
0.01
86.59%
0.01
68.52%
0.03
174.07%
earnings yield
0.02
-
0.01
33.33%
0.02
64.29%
0.03
47.20%
0.03
6.65%
0.02
32.77%
0.01
39.26%
0.02
34.55%
0.03
45.28%
0.03
31.08%
enterprise value
64.78B
-
65.11B
0.51%
68.93B
5.87%
73.34B
6.40%
106.58B
45.32%
206.86B
94.09%
502.02B
142.68%
447.47B
10.87%
359.36B
19.69%
333.20B
7.28%
enterprise value over ebitda
55.36
-
36.10
34.80%
29.80
17.44%
21.26
28.65%
22.71
6.83%
34.89
53.60%
61.56
76.47%
45.48
26.12%
30.02
34.01%
25.05
16.54%
ev to operating cash flow
37.20
-
32.17
13.51%
22.68
29.51%
22.22
2.01%
26.42
18.88%
43.81
65.84%
56.60
29.19%
49.73
12.14%
29.60
40.48%
29.70
0.35%
ev to sales
8.27
-
8.13
1.71%
7.63
6.07%
6.56
14.00%
7.75
18.07%
12.49
61.23%
23.88
91.09%
17.71
25.83%
11.83
33.17%
9.64
18.54%
free cash flow per share
1.25
-
1.54
23.42%
2.64
71.69%
2.59
1.81%
3.01
16.20%
3.25
7.66%
6.32
94.87%
6.25
1.11%
8.45
35.15%
7.05
16.59%
free cash flow yield
0.02
-
0.02
23.42%
0.04
71.69%
0.04
1.81%
0.03
23.02%
0.02
37.21%
0.01
16.79%
0.02
10.62%
0.03
62.89%
0.02
9.30%
graham net net
-1.55
-
-2.41
55.85%
-2.50
3.44%
-0.41
83.69%
6.61
1,723.30%
8.09
22.50%
7.45
7.98%
6.15
17.46%
10.56
71.77%
7.53
28.67%
graham number
18.26
-
12.30
32.62%
12.83
4.31%
17.98
40.07%
31.98
77.93%
36.40
13.80%
48.57
33.45%
57.34
18.05%
68.72
19.84%
76.74
11.68%
income quality
1.28
-
2.15
68.01%
1.89
12.39%
1.27
32.70%
1.08
14.65%
1.01
6.93%
1.33
32.15%
1.12
15.59%
1.26
12.37%
0.97
23.33%
intangibles to total assets
0.17
-
0.18
4.39%
0.18
0.50%
0.16
11.92%
0.11
29.31%
0.09
16.07%
0.08
18.43%
0.17
120.57%
0.14
15.22%
0.11
26.08%
interest coverage
12.40
-
24.21
95.24%
23.02
4.91%
35.55
54.42%
100.66
183.10%
1.05K
-
1.03K
2.05%
142.74
86.12%
interest debt per share
1.80
-
2.08
15.50%
3.63
74.91%
2.82
22.40%
1.38
51.05%
1.17
15.08%
1.14
2.44%
0.20
82.29%
0.20
0.95%
0.23
13.32%
inventory turnover
3.12
-
3.02
2.95%
3.10
2.50%
2.35
24.15%
2.71
15.13%
2.54
6.09%
2.08
18.14%
2.48
19.22%
2.70
9.04%
3.16
16.79%
invested capital
0.17
-
0.30
76.44%
0.78
164.60%
0.45
42.23%
0.10
78.24%
0.08
22.27%
0.06
22.08%
0.01
85.25%
0.01
15.98%
0.01
20.61%
market cap
65.00B
-
65.24B
0.38%
69.85B
7.07%
76.77B
9.90%
118.13B
53.87%
221.13B
87.20%
517.88B
134.19%
462.59B
10.68%
382.31B
17.36%
351.61B
8.03%
net current asset value
4.37B
-
1.18B
73.06%
-1.06B
190.29%
806.48M
175.89%
8.74B
984.15%
11.71B
33.89%
11.62B
0.78%
10.20B
12.19%
15.86B
55.49%
12.39B
21.87%
net debt to ebitda
-0.19
-
-0.07
60.95%
-0.40
445.77%
-0.99
148.63%
-2.46
147.66%
-2.41
2.15%
-1.95
19.18%
-1.54
20.99%
-1.92
24.69%
-1.38
27.78%
net income per share
1.47
-
0.98
33.33%
1.61
64.29%
2.37
47.20%
3.34
40.93%
3.85
15.28%
5.48
42.24%
6.59
20.27%
7.94
20.55%
9.57
20.56%
operating cash flow per share
1.88
-
2.18
15.78%
3.06
40.27%
3.02
1.20%
3.62
19.93%
3.88
7.20%
7.30
87.86%
7.41
1.52%
10.03
35.46%
9.27
7.60%
payables turnover
4.56
-
4.69
2.84%
4.69
0.11%
3.69
21.38%
4.89
32.55%
4.63
5.37%
4.91
6.17%
3.88
21.08%
4.75
22.59%
4.67
1.71%
receivables turnover
4.73
-
5.65
19.43%
7.44
31.83%
6.65
10.65%
7.30
9.74%
7.97
9.20%
10.31
29.36%
11.68
13.27%
9.80
16.09%
9.19
6.21%
research and ddevelopement to revenue
0.12
-
0.11
11.15%
0.09
16.85%
0.09
1.12%
0.09
3.92%
0.09
0.43%
0.10
12.36%
0.10
3.65%
0.09
7.05%
return on tangible assets
0.11
-
0.09
20.35%
0.15
67.80%
0.21
41.68%
0.19
9.09%
0.20
4.08%
0.22
7.43%
0.25
16.69%
0.24
5.06%
0.27
12.66%
revenue per share
8.47
-
8.63
1.88%
9.09
5.27%
10.23
12.57%
12.35
20.76%
13.62
10.26%
17.30
27.00%
20.80
20.27%
25.10
20.65%
28.57
13.83%
roe
0.15
-
0.14
2.10%
0.35
148.03%
0.39
10.45%
0.25
37.27%
0.25
2.60%
0.29
13.61%
0.30
3.80%
0.30
1.19%
0.35
16.53%
roic
0.11
-
0.10
5.43%
0.17
66.52%
0.27
58.83%
0.23
14.99%
0.23
3.83%
0.27
15.39%
0.29
8.77%
0.30
1.26%
0.33
10.02%
sales general and administrative to revenue
0.22
-
0.04
81.02%
0.04
13.26%
0.01
61.51%
0.02
12.85%
0.01
10.29%
0.01
2.12%
0.01
0.46%
0.01
11.37%
shareholders equity per share
10.08
-
6.86
31.90%
4.55
33.76%
6.06
33.27%
13.61
124.65%
15.29
12.35%
19.15
25.20%
22.19
15.87%
26.43
19.13%
27.34
3.45%
stock based compensation to revenue
0.03
-
0.01
41.81%
tangible asset value
7.17B
-
4.33B
39.57%
2.28B
47.48%
4.38B
92.25%
12.77B
191.76%
16.22B
27.04%
20.75B
27.93%
20.55B
0.95%
25.32B
23.23%
28.39B
12.13%
tangible book value per share
7.75
-
4.67
39.80%
2.29
50.95%
4.01
74.93%
11.46
186.24%
13.34
16.36%
17.07
27.93%
16.92
0.88%
20.93
23.73%
23.47
12.13%
working capital
6.02B
-
1.96B
67.46%
1.73B
11.43%
2.35B
35.72%
10.60B
350.20%
13.68B
29.06%
13.40B
2.09%
12.71B
5.15%
18.84B
48.25%
16.77B
10.95%

All numbers in CNY (except ratios and percentages)